Diagnosing Preclinical and Prodromal Neurodegenerative Diseases—The Clinical Is Political-Reference-Cited by-同舟云学术

Diagnosing Preclinical and Prodromal Neurodegenerative Diseases—The Clinical Is Political

Published:2024-05-01 Issue:5 Volume:81 Page:439
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Erickson Claire M.¹,Largent Emily A.¹

Affiliation:

1. Department of Medical Ethics and Health Policy, University of Pennsylvania Perelman School of Medicine, Philadelphia

Abstract

This Viewpoint describes clinical and political considerations for individuals diagnosed with neurodegenerative conditions during the preclinical or prodromal stage.

Publisher

American Medical Association (AMA)

Link

https://jamanetwork.com/journals/jamaneurology/articlepdf/2815106/jamaneurology_erickson_2024_vp_230024_1714578848.46858.pdf

Reference10 articles.

1. The sociology of chronic illness: a review of research and prospects.;Bury;Sociol Health Illn,1991

2. Moving beyond disclosure: stages of care in preclinical Alzheimer’s disease biomarker testing.;Ketchum;Alzheimers Dement,2022

3. Psychological, behavioral and social effects of disclosing Alzheimer’s disease biomarkers to research participants: a systematic review.;Bemelmans;Alzheimers Res Ther,2016

4. Disclosure of preclinical Alzheimer’s disease biomarker results in research and clinical settings: Why, how, and what we still need to know.;Erickson;Alzheimers Dement (Amst),2021

5. Cognitively unimpaired adults’ reactions to disclosure of amyloid PET scan results.;Largent;PLoS One,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ethical Considerations for Identifying Individuals in the Prodromal/Early Phase of Parkinson’s Disease: A Narrative Review;Journal of Parkinson's Disease;2024-07-04

2. The Ethical Landscape of Prodromal Parkinson Disease;Neurology;2024-06-11